A retrospective review was conducted of all cases of head and neck community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infections seen in the senior author's suburban private practice during a 12-month period. An offi ce and hospital chart review was performed for all patients identifi ed with culture-positive CA-MRSA infections. Several parameters were evaluated, including site of infection, prior therapy, imaging, comorbid disease, culture and sensitivities, surgical and medical management, and long-term results. Of the 10 patients identifi ed, 3 had infections of nasal soft tissues, 3 had infections of the lips, 2 had infections of the paranasal sinus, 1 had an infection of the chin, and 1 had a diffuse, hemifacial infection. All patients were managed successfully with a combination of surgical drainage, wound care, and antibiotics. CA-MRSA is a burgeoning problem in otolaryngology. Appropriate management-including early recognition, appropriate empirical therapy, prompt and thorough surgical drainage with culture and sensitivities, correct antibiotic choice, and meticulous postoperative care-appears to offer excellent results. OTOLARYNGOLOGIC COMMUNITY-ACQUIRED MRSA INFECTIONS IN A SUBURBAN PRIVATE PRACTICE Volume 89, Number 10 www.entjournal.com ■ E35
Introduction
This study was submitted to the Institutional Review Board at HCA-Midwest Health System in Kansas City and was determined exempt from IRB review.
Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infection is an infection occurring in the community in an individual who lacks any of the established risk factors for hospital-acquired MRSA (HA-MRSA). These factors include recent hospitalization, long-term care facility residence, the presence of an indwelling catheter, or dialysis. 1 CA-MRSA began to appear sporadically in the early 1980s. 2 Originally felt to be spread from HA-MRSA strains, it has subsequently been determined that CA-MRSA is microbiologically distinct. CA-MRSA isolates generally carry unique chromosomal alleles, including the genetic elements SCCmec IV and V and the cytotoxin Panton-Valentine leukocidin (PVL). SCCmec IV and V confer methicillin (and other antibiotic) resistance in CA-MRSA strains but, in general, CA-MRSA has more antibiotic sensitivity than that seen in HA-MRSA.
PVL causes leukocyte destruction and soft-tissue necrosis. CA-MRSA has a propensity for superfi cial soft-tissue infection, including abscess formation, 3 necrotizing fasciitis, 4 and necrotizing pneumonia. 5 PVL is considered to be the etiologic component in these aggressive CA-MRSA infections. 6 CA-MRSA colonization has skyrocketed from virtually nonexistent to as high as 50% of all S aureus infections and to more than 2% in the healthy U.S. population. 7 There have been several reports in the literature of CA-MRSA infections involving the head and neck, with inappropriate antibiotic treatment given, underscoring the need for greater recognition and understanding of the management of CA-MRSA.
We present a series of patients with head and neck CA-MRSA encountered in a 12-month period in the senior author's (G.Y.S.) private suburban practice. Infection characteristics, management techniques, and outcomes are discussed.
Patients and methods
Ten patients were identifi ed with head and neck CA-MRSA infections in the senior author's private practice in a 12-month period from March 2008 to March 2009-8 men and 2 women. The average age was 42.3 years (mean: 44 yr; range: 21 to 75 yr). Patients were included in this study if they had culture-proven MRSA without any of the criteria for HA-MRSA, including recent hospitalization, long-term care facility residence, the presence of an indwelling catheter, or dialysis. 1 All patients with abscesses (7/10) underwent prompt (within 48 hours) incision and drainage, as well as receiving an Infectious Disease consult from the third author (M.R.D.). When localization was in doubt due to excessive edema, ultrasound was performed using a portable machine with a 3-cm footplate probe. Whenever possible, incisions were made in a cosmetically acceptable area.
All patients underwent culturing performed with a sterile technique. The culture swabs were inoculated on a trypticase soy agar base with 5% sheep's blood, chocolate agar, and MacConkey agar for aerobic culture. The agar plates were then incubated at 35°C in 5% CO 2 and read at 24 and 48 hours. Sensitivities were 8 Because of the presence of inducible clindamycin resistance in MRSA that is resistant to erythromycin and sensitive to clindamycin, a "D-zone test" was also performed in all samples. In this test, disks impregnated with erythromycin and clindamycin, respectively, are set 15 mm apart on an agar plate inoculated with the MRSA in question. After incubation, the inducible phenotype causes a "D" shaped inhibition zone around the clindamycin disk, with blunting of the side facing the erythromycin disk. If the inducible gene is absent, then the zone of inhibition around the clindamycin disk remains circular. 9 All abscess cavities were irrigated with vancomycin solution (2 mg/ml) then packed with quarter-inch gauze soaked in vancomycin. This packing was changed daily until the cavity volume had signifi cantly decreased. All patients received appropriate antibiotics based on sensitivities until all signs of infection had resolved. The patients with paranasal sinus infections were endoscopically cultured and started on nebulized topical antibiotics. All patients were seen as outpatients 1 day, 1 week, and 1 month after undergoing incision and drainage.
Results

Risk factors.
Although none of the patients in this study met the classic criteria for HA-MRSA infection, 5 patients had preexisting conditions that might have predisposed them to infection (table 1). One patient had a history of chronic hepatitis C, 1 had received chemoand radiation therapy for lung cancer 2 years earlier, 1 had a history of insulin-dependent diabetes mellitus; and 2 had undergone endoscopic sinus surgery 13 and 18 months, respectively, before. Cultures of the latter 2 patients taken at the time of their original sinus surgery had been negative for MRSA, and both had received two rounds of oral antibiotics within the previous 6 months. Three patients previously had skin abscesses. However, these had been managed elsewhere and cultures had not been performed.
Sites of infection. The anatomic locations of the CA-MRSA infections in the patients studied are listed in table 1. Three patients' CA-MRSA infections were predominantly nasal soft-tissue infections, 3 had lower lip involvement, 2 had chronic paranasal sinus infections, 1 had diffuse involvement of his entire right lower face, and 1 had a submental abscess. Only 1 patient had been cultured prior to referral, via an attempted intraoral aspiration performed elsewhere.
Treatment. Five patients received empiric therapy prior to referral (table 2) . Of these, only 2 received antibiotics generally considered effective against CA-MRSA in our locale (patients 3 and 7).
All patients with a soft-tissue abscess underwent surgical incision and drainage (I and D), performed using a sterile technique, within 24 hours (fi gures 1 and 2). Four patients had such signifi cant associated edema that ultrasound was employed to help localize the abscess cavity and ensure that no loculations remained. All patients had swabs sent for culture and sensitivities, which returned positive for MRSA. Three had polymicrobial infections; of these, 2 were patients with chronic sinusitis who had undergone previous sinus surgery and had received several courses of antibiotic treatment for their sinusitis in the previous 12 months (table 2) .
Antibiotic sensitivities are reported in table 3. All patients' infections were sensitive to vancomycin, trimethoprim/sulfamethoxazole (TMP/SMX), and tetracycline. Three patients' infections (patients 6, 8, and 9) were resistant to clindamycin as demonstrated on the D-zone test. All of the infections were resistant to erythromycin, oxacillin, and penicillin.
All of the patients who underwent soft-tissue I and D had packing placed, which was to be changed daily (table 4) . Packing was required for a mean time of 1 week (range: 5 to 21 days). Patient 7 was not compliant with daily packing changes and was the only patient who required a second I and D 1 week after the fi rst.
The patient with diffuse hemifacial skin involvement and necrosis was initially evaluated by a dermatologic oncologist for suspected skin cancer. When referred to 2) . Five of these individuals received at least 1 day of intravenous vancomycin. In addition, patient 7 had received one dose of intravenous vancomycin prior to his referral and had experienced a nonallergic histamine-mediated reaction, or "red man's syndrome." He received IV daptomycin for 3 weeks and IV ertapenem for 2 weeks as an outpatient. No other patient received home IV therapy. The mean duration of IV therapy was 4 days.
All of the patients except those with chronic paranasal sinus MRSA infections received oral antibiotics. Most subjects received either oral doxycycline, TMP/SMX, or tetracycline. These oral antibiotics were employed for an average of 26 days. Four patients received oral TMP/SMX (patient 1 for 10 days, patient 2 for 2 weeks, patient 6 for 5 weeks, and patient 10 for 3 weeks). Patient 6 received both doxycycline and TMP/SMX. Both patients with paranasal sinusitis received topical, culture-directed therapy.
At 1-month follow-up, no patient had recurrent infection, and all incisions had healed well except for that of patient 3, who began to have evidence of a depressed scar on her submental drainage site; this was successfully managed with minor scar revision.
Discussion
It is likely that S aureus has been present since the human species evolved, acting as both a commensal and pathologic organism. 10 There exists a repeating pattern of ingenious human intervention to combat this infec- Table 3 . Antibiotic sensitivity profi le
Figure 1. Patient 10. Images show the upper-lip abscess before surgical incision and drainage (A), the incision along the vermilion border, with packing (B), and the infection site 2 weeks after incision and drainage (C).
Figure 2. Patient 5. Images show the nasal tip abscess (A), the hemitransfi xion incision and drainage, with packing (B), and the infection site 2 weeks after incision and drainage (C).
Antibiotic Sensitivity
Tetracycline 100% (10/10) TMP/SMX 100% (10/10) Vancomycin 100% (10/10) Clindamycin 70% (7/10) Erythromycin 0% (0/10) Oxacillin 0% (0/10) Penicillin 0% (0/10) tive agent, followed by equally ingenious modifi cation of the bacterium to resist. Although Alexander Fleming fi rst isolated the penicillin antibiotic from the Penicillium mold in 1929, 11 it was not until 1944 that the fi rst widespread clinical use began. The universal sensitivity of S aureus to penicillin was short-lived. By 1947 the fi rst cases of penicillinase-producing S aureus were reported. 12 Semisynthetic methicillin was developed in the 1950s, again combating S aureus with near total effectiveness. However, by 1961, the fi rst reported cases of resistance developed. 13 Originally sporadic, the prevalence of MRSA has increased exponentially, predominantly in the hospital or chronic-care setting. In 1975, 2.4% of all hospital S aureus cultures were found to be MRSA; this rose to 29% in 1991 and climbed to nearly 50% in 1996. 14 MRSA infections outside the hospital or chronic care setting were rare. Most of the infected individuals had prosthetic devices, were chronic intravenous drug abusers, or had frequently used antibiotics.
Beginning in the late 1980s, increasing reports of CA-MRSA infections in patients without any associated risk factors began to appear. 1, 15 By the mid-1990s, CA-MRSA was reported to have increased 26-fold and has continued to increase at alarming rate, while the incidence of HA-MRSA has remained relatively stable. 16 CA-MRSA was originally felt to be spread from nosocomial strains of MRSA; however its disease pattern differed from that of HA-MRSA pathology. A predilection to superfi cial soft-tissue infection, fasciitis, and abscess formation (including life-threatening necrotizing pneumonia) characterized severe CA-MRSA. [3] [4] [5] The antibiotic resistance pattern also signifi cantly differed: HA-MRSA generally was resistant to most antibiotics except vancomycin while CA-MRSA tended to be sensitive to other antibiotics, as well-specifi cally clindamycin, TMP-SMX, and doxycycline.
Antibiotic resistance has been mapped to the S aureus mec A gene producing penicillin-binding protein PBP2a. HA-MRSA has been found to possess large molecular weight mec A types I, II, and III (34 to 67 kb). 17 CA-MRSA harbors smaller variants, type IV and V (24 kb). The lower weight is felt to result from the exclusion of non-beta lactam antibioticresistant genomes. 18 Another key difference between HA-MRSA and CA-MRSA is the presence of the leukocyte toxin PVL, which is found almost universally in disease-producing CA-MRSA. 19 Panton and Valentine fi rst identifi ed the toxin in 1932 long before the existence of MRSA, noting its association with softtissue infections. 20 Genetic studies have more recently determined the genes LukS-PV and LukF-PV to be the most consistent toxin loci in the chromosomes of CA-MRSA. 21 PVL is not routinely commercially tested, and such a test was not performed in our series. Nevertheless the soft-tissue nature in 8 of 10 of our patients and polyantibiotic susceptibility in all of our patients would strongly suggest both PVL 22 Park et al noted that the prevalence of CA-MRSA in chronic suppurative otitis media rose from 0.7% in 1998 to 11.4% in 2006 while the proportion of HA-MRSA remained stable. 23 Manarey et al reported a 9.22% MRSA infection rate in chronic rhinosinusitis in an outpatient setting. 24 A 2.7% MRSA infection rate in acute rhinosinusitis was reported by Huang and Hung. 25 Other reports of otolaryngologic CA-MRSA infections include series on pediatric neck abscesses, 26 facial abscesses, 27 head and neck cancer, 28 and post-rhytidectomy patients. 29 Our series adds to this growing accumulation of head and neck CA-MRSA infections. Despite the small size of our series, several important features are evident. All of our patients with soft-tissue infections started with a red mark and swelling, which rapidly increased in size. This manifestation is frequently confused with a spider bite, but the CDC warns that this presentation should alert the healthcare professional to possible CA-MRSA, particularly in an endemic area. 16 Empiric antibiotic therapy should treat possible MRSA, as well.
In our series, half of the patients that had received antibiotic therapy prior to referral received a cephalosporin generally not appropriate for MRSA infections. In areas where MRSA prevalence is greater than 10 to 15%, clindamycin, tetracycline, TMP-SMX, and linezolid are all considered reasonable empiric choices. 30 With the exception of patient 6, who was felt to have a dermatologic malignancy, all of our patients with softtissue infections had I and D with culture and sensitivities within 24 hours of referral. Prompt I and D is critical for both therapeutic and diagnostic reasons. Localization of the abscess cavity may sometimes be diffi cult because of concomitant edema. We have found the judicious use of portable ultrasound to be benefi cial in helping to direct the incision location and reveal hidden loculations.
The head and neck surgeon should drain the abscess in an area that will minimize an untoward scar. For example, in the lip the incision should be along the vermilion border. In the nasal tip, a marginal incision should be made along the edge of the medial crura; a hemitransfi xion incision can be added if there is septal involvement.
In the chin, either an intraoral or extraoral approach can be used. The extraoral route has the advantages of preventing oral contamination of the wound and offering more patient comfort with packing. However it has the drawback of a more noticeable scar due to late retraction, as was seen in patient 3. If possible when approaching the chin extraorally, a small incision should be made in the submental crease skin, followed by deeper dissection at a more superior plane in a stairstep fashion. This may prevent late retraction, as recommended in augmentation mentoplasty. 31 A thorough attempt to break all loculations should be made, followed by appropriate antibiotic irrigation. The senior author has found daily packing changes with antibiotic-soaked gauze to be useful in preventing abscess recurrence. It is interesting to note that the only abscess regrowth in our series occurred in a patient 6 days after discharge; this patient admittedly did not return to the clinic for packing changes. Packing generally is only necessary for 7 to 10 days until the size of the abscess cavity has greatly decreased. Once the abscess is drained, patients generally are discharged on sensitivity-appropriate oral antibiotics. The use of outpatient IV antibiotics should not be necessary. While there is no specifi c duration of antibiotic therapy, antibiotics are generally continued until all signs of the infection have disappeared, typically 10 to 14 days.
Standard infection-control measures should be employed for all CA-MRSA-infected patients, both in outpatient and inpatient healthcare settings. 32 Hand washing should be performed with soap and water or alcohol gel, even if gloves are used, after contacting infected patients. Gloves should be changed when moving from a contaminated site to a clean site in the same patient. A gown and eye protection should be worn if there is any risk of body fl uid contact. For inpatients, strong consideration should be given to room isolation or, at the very least, a private room. Upon discharge, counseling should be given to close contacts and household members regarding hand hygiene and wound contact.
In conclusion, CA-MRSA infections in the head and neck are a growing concern. Knowledge of the local prevalence rate and a high degree of suspicion will aid the clinician in diagnosis. Appropriate empiric therapy followed by prompt I and D in a cosmetically acceptable location is ideal. Abscess cavities should be packed. Culture and sensitivities should be performed universally, and antibiotics should be adjusted based on sensitivities. Ultrasound localization of the abscess prior to I and D helps identify the ideal incision site and reduces the chance of hidden loculations. Strict infection-control measures should be enforced.
